NCT04164979 2025-08-11Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal AdenocarcinomaUniversity of California, IrvinePhase 2 Active not recruiting34 enrolled 11 charts
NCT06667050 2024-10-31CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric CancerWest China HospitalPhase 2 Active not recruiting58 enrolled